Pathology · Hepatobiliary and Pancreatic Pathology

Primary biliary cholangitis (PBC) is characterized by a specific autoantibody highly sensitive and specific for the diagnosis. This antibody targets:

  • A Anti-smooth muscle antibody (ASMA) against filamentous actin
  • B Anti-liver-kidney microsomal antibody type 1 (anti-LKM1) against CYP2D6
  • C Anti-mitochondrial antibody (AMA) against the E2 subunit of pyruvate dehydrogenase complex (PDC-E2)
  • D Antinuclear antibody (ANA) sp100 and gp210 pattern
Correct answer: C. Anti-mitochondrial antibody (AMA) against the E2 subunit of pyruvate dehydrogenase complex (PDC-E2)

Explanation

Anti-mitochondrial antibody (AMA), particularly against PDC-E2 (pyruvate dehydrogenase complex E2 subunit), is present in >95% of PBC patients and is highly specific (>99%). It is the diagnostic autoantibody for PBC. ASMA is the hallmark of autoimmune hepatitis type 1. Anti-LKM1 against CYP2D6 defines AIH type 2. ANA with sp100/gp210 pattern can also be seen in AMA-negative PBC but is not the primary marker.

Reference: Robbins & Cotran Pathologic Basis of Disease, 10th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 23,000+ MCQs.

Start free → Log in

More Hepatobiliary and Pancreatic Pathology MCQs

See all Hepatobiliary and Pancreatic Pathology MCQs →